Semax vs Selank: BDNF Cognition vs Anxiolysis Without Sedation

Semax and Selank are two synthetic heptapeptides developed at the same Moscow institute, sharing a stabilizing tail and even an enzyme-inhibition mechanism — yet they're used for opposite goals. One is a cognitive/neuroprotective tool; the other an anxiolytic that doesn't sedate. This guide separates them by mechanism, monoamine profile, evidence, and use case. For the single-compound deep dives, see What Is Semax? and What Is Selank?.

The Short Answer

Semax is the BDNF/cognition peptide — it induces brain-derived neurotrophic factor and leans dopaminergic; Selank is the anxiolytic peptide — it modulates GABAergic genes and leans serotonergic, reducing anxiety without the sedation of benzodiazepines. Both are heptapeptides, both carry a PGP (Pro-Gly-Pro) tail for stability, and both inhibit enkephalinases. Each holds a Russian pharmaceutical registration; neither has Western RCTs or FDA approval. (Dolotov 2006, Selank efficacy)

Same Family, Opposite Jobs

Both peptides came out of the Institute of Molecular Genetics in Moscow and share a glyproline (Pro-Gly-Pro) tail that extends metabolic stability. But their parent sequences — and therefore their effects — differ:

• Semax is built on ACTH(4-7) (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP). Its signature action is BDNF induction via a high-affinity basal-forebrain binding site, with downstream TrkB/MAPK signaling, plus a notably dopaminergic monoamine profile. (Dolotov 2006, Eremin 2005)
• Selank is a tuftsin analog (Thr-Lys-Pro-Arg-Pro-Gly-Pro, TKPRPGP). Its signature action is anxiolysis via GABA-related gene modulation and a predominantly serotonergic profile, plus immune/cytokine effects from its tuftsin lineage. (Selank efficacy)

The shared mechanism is enkephalinase inhibition — both prolong endogenous enkephalins, with Semax somewhat more potent (IC₅₀ ~10 µM vs ~20 µM). (Kost 2001)

Side-by-Side Snapshot

Monoamine Profile: The Practical Difference

The cleanest way to predict how each "feels" in research contexts is the monoamine lean:

• Semax increases serotonin turnover and potentiates dopamine release (Eremin 2005) — a more activating, pro-cognitive signature, consistent with its use in stroke rehabilitation and cognitive research. (Eremin 2005)
• Selank is predominantly serotonergic with GABAergic gene modulation — a calming signature that reduces anxiety while sparing alertness. In a comparative clinical study its anxiolysis matched the benzodiazepine medazepam, but without the sedation, amnesia, or dependence. (Selank efficacy)

This complementary profile (dopaminergic-cognitive vs serotonergic-calming) is why the two are often discussed as a pair — though no published co-administration study has formally tested stacking them.

Evidence & Status

Both peptides rest mainly on the Russian clinical and preclinical literature; neither has Western randomized controlled trials.

• Semax holds Russian pharmaceutical registration for ischemic stroke and optic nerve disease, supported by small controlled trials and preclinical BDNF/neuroprotection data. (Dolotov 2006)
• Selank is used clinically in Russia for generalized anxiety disorder and neurasthenia, with mechanistic support from hippocampal BDNF and GABA gene-expression work. (Intranasal Selank BDNF)

Outside Russia, both are research compounds. Most published studies use intranasal delivery; subcutaneous is also used in research protocols.

Which Should You Choose?

• Cognitive support, neuroprotection, BDNF research → Semax.
• Anxiety reduction with preserved focus → Selank.
• Both goals → their mechanisms are complementary (dopaminergic-cognitive vs serotonergic-anxiolytic), which is the basis for theoretical interest in combining them — though there's no published co-administration trial.

FAQ

What is the difference between Semax and Selank?
Semax is an ACTH(4-7) analog used for cognition and neuroprotection; its signature action is BDNF induction with a dopaminergic lean. Selank is a tuftsin analog used for anxiety relief without sedation; it modulates GABA-related genes with a serotonergic lean. Both are heptapeptides with a PGP stabilizing tail and both inhibit enkephalinases. (Dolotov 2006, Selank efficacy)

Can you take Semax and Selank together?
Their mechanisms are complementary — Semax is dopaminergic and pro-cognitive, Selank is serotonergic and calming — which is the basis for theoretical interest in combining them. However, no published co-administration study has formally tested the combination, so any stacking is unstudied and experimental.

Which is better for anxiety?
Selank is the anxiolytic of the pair. In a comparative clinical study its anxiety-reducing effect matched the benzodiazepine medazepam, but without sedation, memory impairment, or dependence. Semax is more activating and is used for cognition and neuroprotection rather than anxiety. (Selank efficacy)

Which is better for focus and cognition?
Semax is the cognition-oriented peptide. It induces BDNF (a key neuroplasticity factor) and potentiates dopamine, supporting attention and memory research. Selank can preserve or even improve focus as anxiety falls, but its primary role is anxiolysis rather than direct cognitive enhancement. (Dolotov 2006)

Are Semax and Selank approved or proven?
Both hold Russian pharmaceutical registrations — Semax for ischemic stroke and optic nerve disease, Selank for generalized anxiety and neurasthenia — based on the Russian clinical literature. Neither has Western randomized controlled trials or FDA approval, so outside Russia both are research compounds.

Do they cause dependence like benzodiazepines?
Neither Semax nor Selank is associated with benzodiazepine-type tolerance or dependence in the published literature. Selank's main selling point versus benzodiazepines is precisely that it reduces anxiety without sedation, amnesia, or withdrawal.

Next Steps

For reconstitution math and dosing tables, see the Semax 10 mg Protocol and Selank 10 mg Protocol, or use the Semax calculator and Selank calculator.

Bottom line: Semax for BDNF-driven cognition and neuroprotection; Selank for calm-without-sedation anxiety relief. Same peptide family, opposite endpoints.